Published 11 days ago

UN health agency issues alert on falsified semaglutides used for diabetes treatment, weight loss

Summary by UN News

The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – brand name Ozempic – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries.

0 Articles

All

Left

Center

Right

CBC News

Falsified batches of Ozempic, other weight-loss drugs found for sale, WHO warns

The World Health Organization say it has fielded several reports of fake semaglutide — the active ingredient in Novo Nordisk's Wegovy and Ozempic — in all geographic regions of the world since 2022.

11 days ago·Canada

Read Full Article

Arab News

WHO issues warnings on fake diabetes and weight-loss drugs

DUBAI: The World Health Organization (WHO) on Thursday issued warnings on falsified semaglutides used in diabetes and weight-loss drugs in light of three altered batches of products detected in Brazil, the UK and the United States. Semaglutide is the active ingredient used in Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Wegovy. The WHO has been observing

11 days ago·Riyadh, Saudi Arabia

Read Full Article

Publico

WHO again warns against counterfeiting of Ozempic, diabetes medicine that is used for weight loss.

Produtos terão entrado na cadeia de abastecimento de três países: Brasil, Reino Unido e EUA. É a segunda vez que há um alerta desta natureza.

11 days ago·Portugal

Read Full Article

OKDIARIO

Global alert by WHO on the counterfeiting of Ozempic, the diabetes treatment and weight loss.

La Organización Mundial de la Salud (OMS) ha emitido una alerta de falsificación de Ozempic (semaglutidas), de Novo Nordisk, utilizado para el tratamiento de la diabetes tipo 2 y la obesidad, en Brasil, Estados Unidos y Reino Unido.La alerta se refiere a tres lotes falsificados que se han detectado en Brasil en octubre de 2023, en el Reino Unido en octubre de 2023, y en Estados Unidos en diciembre de 2023.El Sistema Mundial de Vigilancia y Monit…

11 days ago

Read Full Article

El Mundo

WHO warns of counterfeit drugs to treat diabetes and weight loss

“Semaglutides are not part of the treatments recommended by the WHO for diabetes control due to their current high cost. The cost barrier makes these products unsuitable for a public health approach” Read

11 days ago·Madrid, Spain

Read Full Article